Literature DB >> 33216612

Adropin: a hepatokine modulator of vascular function and cardiac fuel metabolism.

Bellina A S Mushala1, Iain Scott1.   

Abstract

Adropin is a nutritionally regulated peptide hormone, secreted primarily by the liver, which modulates metabolic homeostasis in a number of tissues. Growing evidence suggests that adropin is an important regulatory component in a number of cardiovascular pathologies, and may be central to the control of cardiac fuel metabolism and vascular function. In this mini-review, we examine the known facets of adropin biology, discuss open questions in the field, and speculate on the therapeutic potential of targeting adropin-related signaling pathways in cardiovascular diseases.

Entities:  

Keywords:  adropin; cardiac metabolism; endothelial biology; energy homeostasis; vascular function

Mesh:

Substances:

Year:  2020        PMID: 33216612      PMCID: PMC7847067          DOI: 10.1152/ajpheart.00449.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  33 in total

Review 1.  Pulmonary arterial hypertension: the clinical syndrome.

Authors:  Yen-Chun Lai; Karin C Potoka; Hunter C Champion; Ana L Mora; Mark T Gladwin
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

2.  Evaluation of the relationship between serum adropin levels and blood pressure in obese children.

Authors:  Ayça Altincik; Oya Sayin
Journal:  J Pediatr Endocrinol Metab       Date:  2015-09       Impact factor: 1.634

3.  Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs.

Authors:  J P Montani; J F Liard; J Schoun; J Möhring
Journal:  Circ Res       Date:  1980-09       Impact factor: 17.367

4.  Adropin is a novel regulator of endothelial function.

Authors:  Fina Lovren; Yi Pan; Adrian Quan; Krishna K Singh; Praphulla C Shukla; Milan Gupta; Mohammed Al-Omran; Hwee Teoh; Subodh Verma
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

Review 5.  Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.

Authors:  Guanghong Jia; Michael A Hill; James R Sowers
Journal:  Circ Res       Date:  2018-02-16       Impact factor: 17.367

6.  Pathogenesis of atherosclerosis: A multifactorial process.

Authors:  Raja B Singh; Sushma A Mengi; Yan-Jun Xu; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002

7.  Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.

Authors:  Evangelos D Michelakis; Vikram Gurtu; Linda Webster; Gareth Barnes; Geoffrey Watson; Luke Howard; John Cupitt; Ian Paterson; Richard B Thompson; Kelvin Chow; Declan P O'Regan; Lan Zhao; John Wharton; David G Kiely; Adam Kinnaird; Aristeidis E Boukouris; Chris White; Jayan Nagendran; Darren H Freed; Stephen J Wort; J Simon R Gibbs; Martin R Wilkins
Journal:  Sci Transl Med       Date:  2017-10-25       Impact factor: 17.956

8.  The Effects of Valsartan and Amlodipine on the Levels of Irisin, Adropin, and Perilipin.

Authors:  Huseyin Tugrul Çelik; Nermin Akkaya; Husamettin Erdamar; Sumeyye Gok; Fatmanur Kazanci; Bora Demircelik; Muzaffer Cakmak; Ramazan Yigitoglu
Journal:  Clin Lab       Date:  2015       Impact factor: 1.138

9.  Adropin deficiency worsens HFD-induced metabolic defects.

Authors:  Shi Chen; Kai Zeng; Qi-Cai Liu; Zheng Guo; Sheng Zhang; Xiao-Rong Chen; Jian-Hua Lin; Jun-Ping Wen; Cheng-Fei Zhao; Xin-Hua Lin; Feng Gao
Journal:  Cell Death Dis       Date:  2017-08-24       Impact factor: 8.469

10.  Inverse Correlation Between Plasma Adropin and ET-1 Levels in Essential Hypertension: A Cross-Sectional Study.

Authors:  Xiaosong Gu; Hui Li; Xinyi Zhu; Haibo Gu; Jianchang Chen; Luchen Wang; Pamela Harding; Weiting Xu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more
  8 in total

1.  The association between serum adropin and carotid atherosclerosis in patients with type 2 diabetes mellitus: a cross‑sectional study.

Authors:  Wen Wei; Hui Liu; Xiuping Qiu; Jushun Zhang; Jianqing Huang; Hangju Chen; Shuilin Qiu; Ruiyu Lin; Shihai Li; Mei Tu
Journal:  Diabetol Metab Syndr       Date:  2022-02-08       Impact factor: 3.320

Review 2.  Adropin's Role in Energy Homeostasis and Metabolic Disorders.

Authors:  Ifrah Ismail Ali; Crystal D'Souza; Jaipaul Singh; Ernest Adeghate
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

3.  Adropin Improves Radiation-Induced Myocardial Injury via VEGFR2/PI3K/Akt Pathway.

Authors:  Bingda Li; Zhenhua Wang; Yuanqiao He; Tianpeng Chen; Yun Zhang; Xingxing Yuan; Ping Li
Journal:  Oxid Med Cell Longev       Date:  2022-06-29       Impact factor: 7.310

4.  Adropin Inhibits Vascular Smooth Muscle Cell Osteogenic Differentiation to Alleviate Vascular Calcification via the JAK2/STAT3 Signaling Pathway.

Authors:  Li Wang; Fulu Jin; Peiyu Wang; Shiqiang Hou; Tao Jin; Xiansong Chang; Liangping Zhao
Journal:  Biomed Res Int       Date:  2022-07-27       Impact factor: 3.246

5.  A transcriptomic analysis of cerebral microvessels reveals the involvement of Notch1 signaling in endothelial mitochondrial-dysfunction-dependent BBB disruption.

Authors:  Min Joung Lee; Jiebo Zhu; Jong Hun An; Seong Eun Lee; Tae Yeon Kim; Eungseok Oh; Yea Eun Kang; Woosuk Chung; Jun Young Heo
Journal:  Fluids Barriers CNS       Date:  2022-08-26

Review 6.  Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.

Authors:  Ana Rita de Oliveira Dos Santos; Bárbara de Oliveira Zanuso; Vitor Fernando Bordin Miola; Sandra Maria Barbalho; Patrícia C Santos Bueno; Uri Adrian Prync Flato; Claudia Rucco P Detregiachi; Daniela Vieira Buchaim; Rogério Leone Buchaim; Ricardo José Tofano; Claudemir Gregório Mendes; Viviane Alessandra Capelluppi Tofano; Jesselina F Dos Santos Haber
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

7.  Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study.

Authors:  Mao Liu; Jiao Ai; Zhuang Shuai; Kai Tang; Zongyu Li; Yin Huang
Journal:  Front Cardiovasc Med       Date:  2021-07-12

Review 8.  Current Knowledge of Selected Cardiovascular Biomarkers in Pediatrics: Kidney Injury Molecule-1, Salusin-α and -β, Uromodulin, and Adropin.

Authors:  Mirjam Močnik; Nataša Marčun Varda
Journal:  Children (Basel)       Date:  2022-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.